With the national “14th Five-Year Plan” clearly outlining the strategic goal of “achieving self-reliance and control in high-end medical equipment,” and the State Council’s “Action Plan for Promoting Large-Scale Equipment Renewal and Consumer Product Trade-in” providing strong support to areas such as medical imaging and surgical robots, active medical devices are entering a pivotal development phase characterized by intelligence, precision, and localization. In recent years, the deep integration of AI technology and medical chips has become the core driving force for industry breakthroughs—from high-precision sensors and edge computing chips to AI-assisted diagnostic algorithms, and technological innovations are reshaping the performance boundaries of medical devices. Simultaneously, policies like the NMPA’s Measures for Supervision and Inspection of Clinical Trial Institutions for Medical Devices have further reinforced quality and safety requirements across the entire life cycle of medical devices, accelerating the industry’s shift toward a dual-driven model of “technology + compliance.”

This forum will focus on the cutting-edge applications of AI and chip technologies in active medical devices, exploring pathways for domestic substitution of core components, intelligent upgrade solutions, and challenges in clinical translation, empowering companies to leverage policy benefits and secure technological leadership. Medtec China concurrently launched ADTE (Advanced Active Device Tech EXPO) to bring together domestic and foreign high-end medical device manufacturers, boosting localization of China’s high-end medical devices.

• High-end medical device manufacturers: heads of the departments of R&D, design, and technology, as well as project/company leaders.
• Equipment suppliers and service providers
• Clinicians, universities and research institutes
• Other professionals interested in high-end active medical devices